Consorci Mar Parc De Salut De Barcelona — Sponsor Intelligence | 12 EU Trials

Filter these 12 trials by condition, phase, country and more.

Open in Search →

12 Registered trials

4 Recruiting

1 Completed trials

1 Countries active

19 Unique IMPs

100% Results reported

Phase III/IV

Phase IV

Phase I (Other)

Phase III/IV: 2 Phase IV: 6 Phase I (Other): 4

100%

1 of 1 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Top IMPs

BEVACIZUMAB 1 MIDAZOLAM HYDROCHLORIDE 1 OMALIZUMAB 1 SULFAMETHOXAZOLE, TRIMETHOPRIM 1

All trials

12 total

PHARMACOLOGICAL STRATEGIES OF INHALED ANTIBIOTHERAPY IN BRONCHIECTASIS WITH CHRONIC BRONCHIAL INFECTION: BRONCHIPHARMA STUDY. Pending

2023-510220-72-00 Phase IV 1 country
Impact of oxygen therapy in exertion in physical activity of patients with fibrotic intertitial lung disease with exertional hypoxemia (AFOX… Pending

2023-510440-20-00 Phase III/IV 1 country
Clinical trial to evaluate the genetic polymorphisms influence in the response to Ranibizumab and Bevacizumab treatment in patients with Age… Pending

2024-518990-33-00 Phase III/IV 1 country BEVACIZUMAB
Omalizumab's dose reduction or increase in the frequency of administration in patients who suffer from allergic severe asthma Pending

2025-520782-48-00 Phase IV 1 country OMALIZUMAB
REstoration with calcifediol of VItamin D deficiency in pulmonary Arterial Hypertension patients (REVIDAH study) Pending

2025-521694-14-00 Phase IV 1 country
Evaluation of the persistency of the preoperative anxiolytic effect of music therapy vs midazolam: electroencephalographic and clinical ana… Pending

2025-522575-29-00 Phase IV 1 country MIDAZOLAM HYDROCHLORIDE
Clinical trial to evaluate the clinical and microbiological impact of methenamine hippurate as an alternative prophylaxis in recurrent urin… Pending

2025-523922-42-00 Phase IV 1 country SULFAMETHOXAZOLE, TRIMETHOPRIM
Study of exposure to substances prohibited by the World Anti-Doping Agency in healthy volunteers (ESPAMA_4). Proof of concept Recruiting

2025-521814-25-01 Phase I (Other) 1 country
Reduced Immunosuppression for Older Adult Kidney Transplant Recipients: the RELEASE study. Recruiting

2025-520535-16-00 Phase IV 1 country
Effects of opioid-free multimodal anesthesia on functional neuroimaging and electroencephalogram Recruiting

2024-520157-20-00 Phase I (Other) 1 country
Study of exposure to substances prohibited by the World Anti-Doping Agency in healthy volunteers (ESPAMA_3). Proof of concept Recruiting

2024-519780-18-00 Phase I (Other) 1 country
A Study on Oral and Intranasal Forms in Healthy Volunteers using Pharmacokinetic Modeling Ended

2024-515461-34-00 Phase I (Other) 1 country

Showing 1–12 of 12 trials

← All sponsors A–Z